2014 Predictions
January 2, 2014
Here’s Our Quick Take on What’s Coming Up in 2014 Meaningful Use Stage 2 and ICD-10 implementation are going to be big headaches for providers
Here’s Our Quick Take on What’s Coming Up in 2014 Meaningful Use Stage 2 and ICD-10 implementation are going to be big headaches for providers
Have a wonderful holiday season and wishing you the best for 2014!
The premise of Marshall Goldsmith’s leadership book, What Got You Here Won’t Get You There, is simple: the habits and work methods that get you
Information for Cloak and Workgroup Users With our recent v2.8 update, we made the default de-identification rules more robust. You’ll need to add fewer rules
Here’s how it starts: Are HL7 interfaces becoming more important or less important with the push for interoperability and the popularity of integrated hospital systems?
Does innovation start with standards? With interfacing and interoperability, there’s an unspoken assumption that innovation starts with standards. It seems like we wait for standards
This dot release contains several new features and enhancement requests. Caristix Users To access v2.8, simply go to the Help menu, and click Check for
“Interfacing costs? They’re too high.” We hear that a lot. The cost is frustrating, especially to physicians who need to implement EMRs for Meaningful Use.
Meaningful Use, the changeover to ICD-10, the 2013 HIPAA Final Omnibus Rule, among other drivers, makes it clear that integration is an essential, critical process.
What is Your Biggest Interfacing Challenge? To gain insight into the issues our users are facing, there is one key question we ask when a
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.